All Access

Health Tech Deals

Health Tech Deals Alerts

Alert

Standard

Health Tech Deals Thought Bubble

Thought Bubble

mustard

BFD Expert Voices - Health Tech Deals

BFD Expert Voices

topics

politics-policy

epstein-files

donald-trump

2026-midterm-elections

immigration

behind-the-curtain

race-and-equity

technology

privacy-tech-regulation

automation-and-ai

tiktok-news

big-tech

social-media

cybersecurity

economy

social-security

inflation

tariffs

federal-reserve

jobs

transportation

business

stock-market-news

retail-news

crypto

media

elon-musk

dealmaking

health

rfk-jr

drug-prices

axios-explains-abortion

public-health

world

israel

axios-explains-ukraine

iran

russia

china

energy-climate

nuclear-energy

climate-energy-policy

climate-change

extreme-weather

alternative-energy

electric-vehicles

science

emerging-tech

biomedicine

newsletters

pittsburgh

atlanta

san-diego

charlotte

boulder

washington-dc

kansas-city

dallas

denver

detroit

des-moines

austin

boston

chicago

cleveland

columbus

houston

indianapolis

miami

nashville

new-orleans

nw-arkansas

philadelphia

phoenix

portland

richmond

salt-lake-city

san-antonio

san-francisco

seattle

tampa-bay

twin-cities

raleigh

huntsville

colorado-springs

axios-local

axios-pro

axios-live

the-axios-show

Popai Health secured $11 million in total funding and plans to raise its Series A in the next 12 to 18 months, CEO Eyal Gurion tells Axios Pro exclusively.

Why it matters: The company is taking a different approach in the crowded health care voice AI segment.

How it works: Popai applies AI to extract data from conversations between clinical and administrative staff and patients. The company primarily sells to providers and payers.

Current use cases include automating documentation of nurse and care manager phone calls. 

The company is able to extract data from the conversations that can identify at-risk patients who might have issues such medication adherence or untreated symptoms.

Gurion says Popai is able provide more data, which can help managers track performance for their teams.

Follow the money: The funding was led by venture firms Team8 and NEA. It gives Popai over two years of runway, but it plans to raise sooner than that.

What they're saying:  Eyal and NEA's Blake Wu acknowledged that the space has become increasingly crowded. 

Eyal says Popai is able to improve performance of AI agents because it integrates with customers' CRMs, EHRs and practice management systems.

Wu argues that Popai is stickier than other AI agent companies because its AI outputs are not standardized notes. 

"Our view is that this is the kind of moat around commoditization in the category," Wu says.

State of play: There's been a rush of capital flowing into the space, with several fundraises for phone-focused AI startups in recent weeks.

Hyro raised $45 million for AI call center agents last month.

In September, Assort Health raised a $76 million Series B round, while Confido Health raised a $10 million Series A.

Those rounds follow EliseAI's whopping $250 million Series E round in August. The startup, focused on health care and property management, was valued at over $2.2 billion.

Zoom in: Founded in June 2024, Popai currently has three paying customers but plans to sign a total of six by the end of the year.

Exclusive: Popai Health raises $11M and eyes Series A

The company plans a Series A raise in 12 to 18 months.

an illustration of a circuitboard with a red-cross-shaped section illuminated 

Popai Health secured $11 million in total funding and plans to raise its Series A in the next 12 to 18 months, CEO Eyal Gurion tells Axios Pro exclusively.Why it matters: The company is taking a different approach in the crowded health care voice AI segment.

Exclusive: Popai Health raises $11M and eyes Series A

What to read next